Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma
Clinical trial NCT04805203 · TERMINATED
Trial details
- NCT number
- NCT04805203
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2022-12-31
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.